207_Combined course Presentations

Take Home Message (Early Stage HL)

 Combined modality therapy still represents a standard for patients affected with early stage HL. Chemotherapy alone can be considered in some patients, after a discussion with a Radiation Oncologist to hear about PROs/CONs in his/her particular case

 Interim-PET studies confirmed that even PET-negative patients are more likely to fail without RT and modification of the treatment schedule according to PET-scan is experimental

 Radiation oncologists should be aware of the opportunity to minimize the risks of late toxicity by using smaller fields and most recent technological improvements in radiation planning and delivery.

 A balanced multi-disciplinary evaluation of individual patients should be encouraged for the proper selection of the best strategy according to age, disease extension, secondary cancer and heart diseases risk profile.